Retatrutide (6mg/12mg) is an innovative peptide that is attracting attention for its potential for weight loss and the treatment of metabolic diseases, especially type 2 diabetes. By acting as an agonist of three key hormones – GLP-1 (glucagon-like peptide-1), GIP (gastrin-inhibitory polypeptide) and glucagon – Retatrutide helps regulate appetite, improve glucose metabolism and promote fat burning, making it a powerful tool for managing obesity and metabolic disorders.
Key Benefits of Retatrutide:
Significant Weight Loss: Clinical studies have shown that Retatrutide can help users achieve up to 24% weight loss by reducing appetite and increasing satiety.
Improve blood sugar control: By stimulating insulin secretion, Retatrutide regulates blood sugar levels and is beneficial for people with type 2 diabetes.
Regulate appetite and metabolism: By activating GLP-1, GIP, and glucagon receptors, Retatrutide helps reduce hunger and improves fat breakdown.
Reduce cardiovascular risk: Weight loss and metabolic improvements can lower the risk of heart disease, which is a common concern in obesity and diabetes.
Improve lipid profile: Retatrutide may help lower LDL cholesterol and triglycerides, improving overall health.
Liver health potential: The peptide is being studied for its effects on nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).
Clinical Studies:
Retatrutide has undergone extensive clinical trials, with results suggesting a promising future in weight management and the treatment of metabolic diseases:
Phase 1: Showed significant weight loss and appetite control with minimal side effects.
Phase 2: Achieved 15%–24% weight loss in participants and improved blood sugar regulation.
Phase 3: Focused on long-term benefits such as reduced cardiovascular risk and improved liver health.
Proper Use and Dosage:
Retatrutide is administered by subcutaneous injection, usually once a week. The starting dose is 2mg, which can be increased depending on the user’s needs. Ensure the correct dosage by consulting a healthcare professional before starting the regimen.
Storage Instructions:
To maintain the stability and effectiveness of Retatrutide, it should be stored at a temperature between 2°C and 8°C in a refrigerator. Transport is carried out in insulated coolers to ensure proper temperature control during shipment.
Retatrutide Dosage:
The dosage of Retatrutide depends on the individual needs and condition of the patient, therefore, prior to use, consultation with a healthcare professional is mandatory to determine the correct dosage and method of administration.
Method of administration:
Retatrutide is administered by subcutaneous injection once a week. The starting dose is usually 2 mg, which can be increased to 6 mg or 8 mg, depending on the patient’s needs. If a dose is missed, it should be administered as soon as possible, but a double dose should not be given.
Additional instructions for use:
1 unit corresponds to 1 division on the dosing disc (or the number that appears when the disc is turned). Inject into the abdomen or front of the thigh. After injection, wait 10 seconds before removing the needle. It is recommended to rotate injection sites to avoid irritation.
Pen Information:
Retatrutide 6mg Pen: Contains 120 units of 50μg. Unit Conversion to Milligrams:
1 unit = 50μg
10 units = 0.50mg
20 units = 1mg
30 units = 1.5mg
40 units = 2mg
Retatrutide 12mg Pen contains 120 units of 100μg. Here are examples of converting units to milligrams for Retatrutide 12mg:
1 unit = 100μg
10 units = 1mg
20 units = 2mg
25 units = 2.5mg
40 units = 4mg
60 units = 6mg
SKU Variants:
Retatrutide 6mg – SKU: RET-6MG
Retatrutide 12mg – SKU: RET-12MG
